重慶建工(600939.SH)申請非公開定向債權融資
格隆匯12月23日丨重慶建工(600939.SH)公佈,為進一步拓寬融資渠道,優化資產負債結構,公司於2020年12月22日召開第四屆董事會第二十二次會議,審議通過了《關於公司申請非公開定向債權融資的議案》,同意公司與投資人、資產服務機構簽署《投資協議》,申請非公開定向債權融資。本次融資是公司在四川金融資產交易所有限公司掛牌發行的非公開定向債權投資工具(以下簡稱“本期投資工具”),投資人以理財產品募集資金投資於公司掛牌的本期投資工具,並委託資產服務機構提供本期投資工具項下資產服務。金額不超過10億元,期限2+N年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.